Latest / Cyrona Cell Podcast: Stem Cell Therapy in Malaysia / Stem Cell Therapy for Anoxic Brain Injury: Supporting Brain Recovery After Oxygen Loss
Transcript
- 0:00SPEAKER_00: You know those sci-fi movies, right?
- 0:01SPEAKER_00: Like a character gets critically injured, they get shoved into some glowing futuristic water tube, uh, a few blue lights flash, and ten seconds later they just step out completely cured.
- 0:12SPEAKER_01: Aaron Ross Powell Oh, yeah, magically regenerated.
- 0:14SPEAKER_01: It's uh it's the ultimate medical fantasy, really.
- 0:17SPEAKER_01: The idea that we possess this biological reset button capable of just reversing severe cellular destruction overnight.
- 0:24SPEAKER_00: Aaron Ross Powell Right.
- 0:24SPEAKER_00: And for a long time, the way pop culture and frankly some highly aggressive medical tourism marketing talked about stem cells, you'd think we actually had those healing pods in the back room of a clinic somewhere.
- 0:35SPEAKER_00: Trevor Burrus, Jr.
- 0:35SPEAKER_01: Yeah.
- 0:35SPEAKER_01: Just inject some magical cells and boom, brand new tissue.
- 0:38SPEAKER_00: Aaron Ross Powell Exactly.
- 0:39SPEAKER_00: But today, for you listening, we are stripping away the snake oil and the miracle cure hype.
- 0:45SPEAKER_00: We are taking a deep dive into the grounded physical reality of regenerative medicine.
- 0:50SPEAKER_01: Aaron Powell And we're applying it to what is arguably the most complex, unforgiving environment in the human body, which is the brain.
- 0:57SPEAKER_00: Our sources today revolve around a really fascinating set of clinical protocols from Cyrona Cell.
- 1:03SPEAKER_00: They're a doctor-led stem cell therapy and regenerative medicine center operating out of Kuala Lumpur, Malaysia.
- 1:09SPEAKER_00: Trevor Burrus, Jr.
- 1:10SPEAKER_01: Yeah, and what stands out immediately in their documentation is their patient base.
- 1:15SPEAKER_00: Right, because they serve the local population, but they also have this massive influx of international travelers flying in from places like Australia and the Middle East.
- 1:25SPEAKER_00: And they're specifically seeking out structured medically improvised cell therapy for severe neurological injuries.
- 1:32SPEAKER_01: Aaron Powell Which tells us that these patients and their families are actively searching for powerful adjunct therapies, something that goes beyond the standard of care currently available in their home countries.
- 1:42SPEAKER_00: Our mission today is to figure out the underlying biology of why that is.
- 1:46SPEAKER_00: We are going to look at how ethically sourced cells act as a biological support team for a damaged brain rather than acting like mechanical replacement parts.
- 1:54SPEAKER_00: Okay, let's unpack this.
- 1:55SPEAKER_01: Yeah, let's do it.
- 1:56SPEAKER_00: Because before we can even touch on the treatment, we need to understand the specific environment of the injury itself.
- 2:02SPEAKER_00: Anoxic brain injury literally means the brain is starving for oxygen, right?
- 2:06SPEAKER_01: Right, exactly.
- 2:08SPEAKER_01: But looking at these clinical sources, it isn't actually the temporary starvation that does the long-term damage, it's what happens after.
- 2:15SPEAKER_01: The initial oxygen deprivation is really just the match that lights the forest fire.
- 2:20SPEAKER_00: Because the brain is basically an absolute metabolic glutton.
- 2:24SPEAKER_00: I mean, it makes up maybe 2% of your body weight, but it demands 20% of your oxygen supply just to maintain basic cellular function.
- 2:32SPEAKER_01: Yeah, it's incredibly demanding.
- 2:34SPEAKER_01: So when that oxygen gets cut off, whether that's from a sudden cardiac arrest, near drowning, severe choking, or even a drastic drop in blood pressure, the nerve cells immediately start to fail.
- 2:45SPEAKER_00: Because they can't produce ATP, which is their energy currency.
- 2:48SPEAKER_01: Exactly.
- 2:49SPEAKER_01: They run out of gas almost instantly.
- 2:50SPEAKER_00: And without that energy, the cells basically burst, right?
- 2:54SPEAKER_00: Releasing all their internal contents into the surrounding brain tissue.
- 2:57SPEAKER_01: Right.
- 2:58SPEAKER_01: And that triggers a massive catastrophic cascade.
- 3:02SPEAKER_01: Even if the paramedics arrive and the heart restarts and oxygen is restored, the brain doesn't just go back to normal.
- 3:09SPEAKER_00: Because the tissue is now flooded with dead cell debris, so the immune system panics and launches this massive inflammatory response to clean up the damage, which causes severe swelling.
- 3:20SPEAKER_01: Yeah, it's a total crisis response.
- 3:22SPEAKER_01: And the tiny micro blood vessels that are supposed to deliver nutrients, they become compressed or damaged, leading to chronic low blood flow.
- 3:30SPEAKER_00: There's a detail in the sireno cell protocols regarding the blood brain barrier that highlights just how hostile this environment becomes.
- 3:37SPEAKER_00: Usually that barrier is a strict security checkpoint, right?
- 3:40SPEAKER_01: Yeah, it's made of these tightly packed endothelial cells that prevent toxins and systemic immune cells in your bloodstream from entering the brain.
- 3:48SPEAKER_01: Under normal conditions, it is basically an impenetrable wall.
- 3:51SPEAKER_00: But during an anoxic event, because those barrier cells are also starved of oxygen, they literally shrink.
- 3:57SPEAKER_01: Right.
- 3:57SPEAKER_00: The tight junctions holding them together break apart.
- 4:00SPEAKER_01: The security gates are just left wide open.
- 4:02SPEAKER_01: So suddenly, peripheral immune cells and inflammatory markers from the rest of your body just flood into the delicate brain tissue, hyper-accelerating the damage.
- 4:11SPEAKER_01: The brain is trying to protect itself, but it ends up locked in this chronic state of toxic inflammation.
- 4:17SPEAKER_00: Okay, let me play devil's advocate here for a second, because if you suffer an injury like this, you are immediately put into standard neurological care.
- 4:25SPEAKER_00: We have anti-seizure medications to control electrical misfires, we have muscle relaxants for spasticity.
- 4:31SPEAKER_00: Trevor Burrus, Jr.
- 4:31SPEAKER_01: Right, and intensive physical and speech therapy to rewire movement.
- 4:35SPEAKER_00: Exactly.
- 4:35SPEAKER_00: So wait, if those are the standard, why look into regenerative medicine at all?
- 4:39SPEAKER_00: Aren't they designed to handle this exact cascade?
- 4:42SPEAKER_01: Aaron Powell Well, no responsible neurologist would ever suggest abandoning standard care.
- 4:46SPEAKER_01: I mean, those therapies are vital for survival and basic rehabilitation.
- 4:51SPEAKER_01: But there's a physical limit, a gap, really, in what standard care can achieve.
- 4:56SPEAKER_00: Because physical therapy helps you build new pathways using the healthy tissue you have left, and medications suppress the outward symptoms like seizures.
- 5:04SPEAKER_00: But they don't fix the underlying problem inside the tissue.
- 5:07SPEAKER_01: Right.
- 5:07SPEAKER_01: None of those standard interventions are capable of crossing into the brain tissue and actively turning off that toxic, chronic inflammatory storm happening at the cellular level.
- 5:17SPEAKER_00: They manage the symptoms of the fire, but they don't actually put the fire out.
- 5:22SPEAKER_01: Perfect way to put it.
- 5:23SPEAKER_01: They leave the brain in this really hostile microenvironment, which makes it incredibly difficult for the surviving neurons to heal or for rehabilitation to even stick.
- 5:33SPEAKER_01: And that inability to change the internal cellular environment is exactly the gap regenerative medicine is trying to fill.
- 5:40SPEAKER_00: Which explains the explosion of medical tourism for stem cells.
- 5:43SPEAKER_00: Desperate families are just looking to put out that fire, but you know, that desperation breeds exploitation, which brings us to how a clinic actually separates itself from the hype.
- 5:53SPEAKER_01: Yeah, and Sarona cells approach is interesting.
- 5:55SPEAKER_01: Starting with their name, Sarona comes from a Celtic goddess of health and protection.
- 5:59SPEAKER_00: Which is a nice ethos.
- 6:01SPEAKER_00: But looking at their lab standards, they back it up with intense biological rigor.
- 6:05SPEAKER_00: They use umbilical cord-derived cells, specifically early passage WJMSCs.
- 6:10SPEAKER_01: Let's define that because it's super important.
- 6:12SPEAKER_01: The Winji J stands for Wharton's Jelly.
- 6:14SPEAKER_00: That's the gelatinous tissue inside the umbilical cord that insulates the blood vessels, right?
- 6:19SPEAKER_01: Yes, exactly.
- 6:19SPEAKER_01: Wharton's jelly is incredibly rich in a specific type of stem cell called meschymal stem cells, or MSCs.
- 6:26SPEAKER_01: Cirona cell sources these from healthy full-term deliveries with complete informed donor consent.
- 6:33SPEAKER_00: So they extract the cells from the discarded umbilical cord, meaning no embryos are harmed or utilized at all.
- 6:39SPEAKER_00: Right.
- 6:39SPEAKER_00: And the sources make a very hard point of stating they strictly do not use embryonic stem cells or experimental pluripotent stem cells.
- 6:48SPEAKER_00: For you listening, what is the actual danger of a pluripotent cell?
- 6:52SPEAKER_00: The marketing always makes them sound superior because they can turn into anything.
- 6:56SPEAKER_01: Well, pluripotent cells can turn into any tissue in the human body, which sounds fantastic until you realize you can't control what they turn into once they are inside a patient.
- 7:05SPEAKER_01: Oh wow.
- 7:06SPEAKER_01: Yeah.
- 7:06SPEAKER_01: They have a known documented risk of forming teratomas, which are these complex tumors containing random tissues like hair, bone, or teeth.
- 7:14SPEAKER_00: That is terrifying.
- 7:15SPEAKER_01: It is.
- 7:15SPEAKER_01: So Cyron cell avoids them entirely for safety reasons.
- 7:19SPEAKER_01: By using multipotent mesenchymal stem cells from Wharton's jelly, they're using cells that are biologically stable, have a much lower risk of tumor formation, and possess what we call immune privilege.
- 7:30SPEAKER_00: Aaron Powell Meaning the patient's immune system won't immediately attack and reject them as foreign invaders, even without matching blood types.
- 7:37SPEAKER_01: Exactly.
- 7:37SPEAKER_01: They basically fly under the radar of the immune system.
- 7:40SPEAKER_01: And just as importantly, Cerona cell processes these cells in BSL2, CGMP certified laboratories.
- 7:46SPEAKER_00: I want to break those acronyms down because to a patient, BSL II and CGMP just sound like corporate alphabet soup, but they're really the dividing line between a medical product and a science experiment.
- 7:57SPEAKER_01: Definitely.
- 7:58SPEAKER_01: BSL2 is biosafety level 2, meaning the lab has strict ventilation and containment protocols to prevent biological contamination.
- 8:06SPEAKER_00: And CGMP stands for current good manufacturing practice.
- 8:10SPEAKER_00: It means the lab doesn't just grow cells in a dish.
- 8:12SPEAKER_00: They run strict quality control checks on every single batch to confirm identity, sterility, and viability before it ever reaches a syringe.
- 8:21SPEAKER_01: Yeah, so you know exactly how many living cells are in the dose, and you know there are no bacterial contaminants hitching a ride.
- 8:27SPEAKER_00: But I have to challenge the core mechanism here.
- 8:29SPEAKER_00: Because when I hear stem cell transplant for brain injury, I picture doctors literally swapping out dead brain cells for new ones so they can turn into fresh neurons, like replacing a burnt-out spark plug.
- 8:41SPEAKER_00: Is that what's happening?
- 8:42SPEAKER_01: Well, what's fascinating here is that the biological reality is completely different and honestly far more elegant than swapping out parts.
- 8:50SPEAKER_01: The MSCs do not need to engraft and become neurons to heal the brain.
- 8:56SPEAKER_00: Wait, really?
- 8:57SPEAKER_00: If they aren't becoming brain cells, what is their purpose?
- 9:00SPEAKER_01: They function almost entirely through what is called a peracrine effect.
- 9:04SPEAKER_01: Think of them as a biological support team.
- 9:06SPEAKER_01: When these stem cells enter the body, they detect the chemical distress signals coming from the damaged brain.
- 9:11SPEAKER_00: Oh, so they migrate toward the inflammation, but instead of trying to become local tissue, they act as microscopic pharmacies.
- 9:18SPEAKER_01: Exactly.
- 9:18SPEAKER_01: They release this massive payload of chemical signals, growth factors, and neurotrophic factors directly into the surrounding environment.
- 9:26SPEAKER_00: So they are fundamentally altering that toxic microenvironment we discussed earlier.
- 9:30SPEAKER_00: They chemically instruct the overactive immune cells to stand down, stopping the chronic swelling.
- 9:36SPEAKER_01: Right, and they secrete vascular endothelial growth factor to stimulate angiogenesis, which is the creation of new, healthy blood vessels to restore oxygen flow.
- 9:46SPEAKER_00: And most importantly, they stimulate the brain's own dormant progenitor cells, coaching the body's natural repair mechanisms back to life.
- 9:54SPEAKER_00: So it's a rescue mission for the environment, not a parts replacement.
- 9:57SPEAKER_01: Precisely.
- 9:58SPEAKER_00: But if these cells are processed in a high-security BSL2 lab, getting them safely into a highly protected organ like the brain sounds like a logistical nightmare.
- 10:08SPEAKER_00: Are we talking about drilling into the skull to deliver this support team?
- 10:12SPEAKER_00: Like walk us through the physical patient journey at a clinic like this.
- 10:15SPEAKER_01: It's surprisingly non-invasive, actually, but it is heavily structured.
- 10:19SPEAKER_01: It starts with a rigorous medical evaluation.
- 10:22SPEAKER_00: Yeah.
- 10:22SPEAKER_01: The doctors at CironaCell aren't just rubber stamping everyone who walks through the door.
- 10:26SPEAKER_00: They review MRI or CT stands, analyze the exact timeline of the anoxic event, look at current medications, and establish grounded functional goals.
- 10:36SPEAKER_01: Yeah, they are targeting very specific improvements, like increasing physical stamina for rehab, steadying disrupted sleep cycles, or slightly reducing muscle spasticity.
- 10:46SPEAKER_01: They aren't promising someone who is nonverbal will suddenly give speech next week.
- 10:51SPEAKER_00: The transparency is key?
- 10:52SPEAKER_00: Once those realistic goals are set and the cells clear all lab testing, the administration is typically done via simple, comfortable intravenous drip.
- 11:02SPEAKER_01: Right.
- 11:02SPEAKER_00: Wait, an IV in the arm.
- 11:03SPEAKER_00: How do the cells get from the arm to the brain?
- 11:06SPEAKER_01: Because of that paracrine homing mechanism we mentioned.
- 11:08SPEAKER_01: The cells are drawn to the chemical alarm bells ringing in the brain.
- 11:12SPEAKER_01: They circulate through the bloodstream and gather at the sites of highest inflammation.
- 11:15SPEAKER_00: Ah, I see.
- 11:16SPEAKER_00: And this is followed by a long-term monitoring phase, working alongside the patient's existing neurologists and physical therapists back home to track the functional gains over months.
- 11:25SPEAKER_01: Exactly.
- 11:26SPEAKER_01: Now, in the middle of this clinical pathway, the sources detail an added value service that is really important to understand exosomes.
- 11:33SPEAKER_00: Yeah, I really want to dissect this.
- 11:35SPEAKER_00: Serona cell offers exosome therapy alongside the live stem cells.
- 11:40SPEAKER_00: What is an exosome, biologically speaking?
- 11:43SPEAKER_01: Aaron Ross Powell Well, if the stem cells are the support team, exosomes are the physical tools they use to communicate.
- 11:50SPEAKER_01: Exosomes are a tiny nanoscale lipid bubbles, basically microscopic fat spheres that are released by the stem cells.
- 11:57SPEAKER_00: Aaron Powell They don't contain a nucleus or DNA, so they aren't alive in the traditional sense, but they are packed full of the messenger RNA, growth factors, and anti-inflammatory proteins we've been talking about.
- 12:06SPEAKER_00: Right.
- 12:07SPEAKER_00: I want to make sure we visualize this correctly because analogies often fail to capture the physical reality.
- 12:12SPEAKER_00: If the damaged brain is a chaotic, stalled construction site, the local workers, meaning the surviving brain cells, are exhausted, disorganized, and surrounded by inflammatory debris.
- 12:22SPEAKER_01: That is a very accurate picture of anoxic injury.
- 12:25SPEAKER_00: And the live stem cells we infuse are like elite project managers arriving at the site.
- 12:30SPEAKER_00: They don't pick up hammers, they walk around, assess the damage, and start managing the environment.
- 12:35SPEAKER_01: I like that analogy.
- 12:36SPEAKER_00: So the exosomes then are the text messages and the physical blueprints stuffed inside waterproof tubes that those managers hand out to the local workers to get the job done right.
- 12:47SPEAKER_01: That is the perfect way to ground it in reality.
- 12:50SPEAKER_01: The exosomes physically float over to the exhausted local worker cells.
- 12:54SPEAKER_01: Because they are made of the same lipid material as the cell's outer wall, they seamlessly fuse with the damaged cell's membrane.
- 13:01SPEAKER_00: Wow.
- 13:02SPEAKER_01: Yeah, they open up and drop those chemical blueprints directly inside, instructing the cell on exactly which proteins to synthesize to repair itself and clear the debris.
- 13:11SPEAKER_00: Here's where it gets really interesting because exosomes are nanoparticles, right?
- 13:14SPEAKER_00: A fraction of the size of a whole cell.
- 13:16SPEAKER_00: So they have zero issue crossing the blood-brain barrier.
- 13:19SPEAKER_01: Exactly.
- 13:20SPEAKER_01: Even if the barrier has started to heal and close back up, these lipid bubbles slip right through, flooding the construction site with clear calming instructions.
- 13:29SPEAKER_00: So by providing extra exosomes alongside the stem cells, you are dramatically amplifying the signal, ensuring the surviving brain tissue gets the message to begin repairing the microenvironment.
- 13:42SPEAKER_00: Exactly.
- 13:43SPEAKER_00: Okay.
- 13:43SPEAKER_00: Theory and blueprints are wonderful, but show me the data.
- 13:46SPEAKER_00: Talking about lipid bubbles fusing with membranes is one thing, seeing a patient regain function is another.
- 13:51SPEAKER_01: And this is where managing expectations meets clinical reality.
- 13:55SPEAKER_01: Cyrona Cell maintains that this is an adjunct therapy, and results vary wildly based on the severity of the initial oxygen loss and the age of the patient.
- 14:04SPEAKER_00: But they do anchor their protocols in published human data.
- 14:08SPEAKER_00: The sources highlight two specific studies that I want to look at.
- 14:11SPEAKER_00: The first is a phase I study out of the University of Health Sciences in Turkey.
- 14:15SPEAKER_01: Right.
- 14:15SPEAKER_01: They looked at adults living with hypoxic, ischemic, encephalopathy, which is the clinical term for the exact lack of oxygen and blood flow damage we've been dissecting.
- 14:24SPEAKER_00: These were adult patients who had been living with the chronic effects of the injury for at least six months.
- 14:30SPEAKER_00: They received Wharton's jelly-derived mesenchymal stem cells, including via IV delivery, which closely mirrors the Cyrona cell methodology.
- 14:39SPEAKER_01: Yeah, and the researchers reported that the protocol was feasible, and they documented measurable improvements in functional scores during the follow-up period.
- 14:47SPEAKER_01: Patients actually showed signs of recovering lost baseline abilities.
- 14:52SPEAKER_00: But the study also noted side effects, which I think we really have to emphasize.
- 14:56SPEAKER_00: It reported mild fever, headache, and muscle pain in some patients shortly after the infusion.
- 15:01SPEAKER_00: It isn't a flawless, magical experience.
- 15:04SPEAKER_01: No, not at all.
- 15:05SPEAKER_01: Your body is reacting to a massive influx of biological signals.
- 15:09SPEAKER_01: It is a serious medical procedure.
- 15:11SPEAKER_01: The fever is often just a mild immune response to the sudden presence of the exosomes and pericrine signals.
- 15:17SPEAKER_00: It shows the treatment is active, but it requires medical supervision to manage safely.
- 15:21SPEAKER_00: Now, the second study mentioned is even more compelling because it targets a completely different demographic and uses a wild delivery method.
- 15:28SPEAKER_01: Oh, you mean the passion study from UMC Utrecht and Utrecht University in the Netherlands?
- 15:33SPEAKER_00: Yes.
- 15:34SPEAKER_00: They focused on newborns who had suffered a perinatal arterial ischemic stroke.
- 15:39SPEAKER_00: Essentially a severe oxygen deprivation injury to the brain occurring right around the time of birth.
- 15:45SPEAKER_01: Right.
- 15:46SPEAKER_01: And the delivery method is really fascinating.
- 15:48SPEAKER_00: The delivery method is what stopped me in my tracks.
- 15:51SPEAKER_00: They didn't use an IV drip, they used intranasal administration, spraying the mesenchymal stem cells into the nasal cavity.
- 15:59SPEAKER_00: How does that not just drip down into the stomach or get sneezed out?
- 16:03SPEAKER_00: Like, how do cells in the nose physically reach the brain?
- 16:06SPEAKER_01: It sounds absurd until you look at the anatomy.
- 16:10SPEAKER_01: At the very top of your nasal cavity is the cribriform plate, which is a porous bone that houses the olfactory nerves, the nerves responsible for your senses smell.
- 16:18SPEAKER_00: And those nerves connect directly into the brain, completely bypassing the blood-brain barrier.
- 16:23SPEAKER_01: Precisely.
- 16:24SPEAKER_01: So they are using the olfactory nerve as a physical highway to march the stem cells directly into the central nervous system.
- 16:30SPEAKER_00: That is wild.
- 16:31SPEAKER_00: And in this two-year safety study, the researchers reported no serious adverse events related to the treatment.
- 16:37SPEAKER_00: But the efficacy signals were the real headline here.
- 16:41SPEAKER_01: Yeah, when compared to a non-treated control group, the infants who received the intranasal stem cells showed highly encouraging neurodevelopmental progress, specifically in their motor outcomes.
- 16:53SPEAKER_00: So the babies who got the cells had better physical movement and motor control two years later.
- 16:58SPEAKER_00: Why is there such a focus on infants in regenerative studies compared to adults, though?
- 17:03SPEAKER_01: Well, it really comes down to neuroplasticity.
- 17:05SPEAKER_01: An adult brain is relatively fixed.
- 17:08SPEAKER_01: You know, it's much harder to convince it to forge new pathways.
- 17:11SPEAKER_01: But an intant's brain is highly plastic.
- 17:14SPEAKER_01: It is actively trying to wire itself.
- 17:16SPEAKER_00: Ah, I see.
- 17:16SPEAKER_00: So when you introduce stem cells and exosomes into an infant's brain after an injury, those calming signals provide a biological scaffold during a critical window of development, allowing the brain to wire around the damage much more effectively than an adult brain could.
- 17:30SPEAKER_01: Exactly.
- 17:31SPEAKER_01: If we connect this to the bigger picture, tracking these specific safety profiles and documenting slow, steady functional improvements, like a child having better motor control two years down the line, is exactly how responsible medical science progresses.
- 17:46SPEAKER_00: Right.
- 17:46SPEAKER_00: You don't jump to claiming you can cure brain damage overnight.
- 17:50SPEAKER_01: You build your protocols around the grounded reality of the data, you monitor the patients, you adjust the therapies, and you prioritize long-term trust over a quick, profitable procedure.
- 18:00SPEAKER_00: Yeah, if a clinic like Zarona Cell reviews a patient's scans and determines the cellular environment is too far gone to benefit, they decline the procedure.
- 18:08SPEAKER_01: Which is a stark contrast to the predatory clinics that promise the world.
- 18:12SPEAKER_00: To bring all of this together for you listening, regenerative medicine for an anoxic brain injury is not about magical replacement parts.
- 18:19SPEAKER_00: It is about fundamentally changing the internal microenvironment of the brain.
- 18:23SPEAKER_01: Right.
- 18:23SPEAKER_01: Clinics like CeronaCell are pioneering this by combining ethical, multipotent cell sourcing, strict BSL2 lab standards, and realistic doctor-led rehabilitation.
- 18:34SPEAKER_00: They are equipping the brain with the biological support team it needs to calm the chronic inflammation, stepping in exactly where standard physical therapies hit their physical limit.
- 18:44SPEAKER_00: Exactly.
- 18:44SPEAKER_00: And honestly, this matters to you even if you never experience a severe neurological injury.
- 18:50SPEAKER_00: What we are talking about today represents a massive paradigm shift in how human beings view medicine.
- 18:55SPEAKER_00: For centuries, we have treated the human body like a mechanical engine.
- 18:59SPEAKER_00: If a gear breaks, you surgically cut it out and try to bolt a new one in its place.
- 19:03SPEAKER_01: Yeah, and that mechanical view of biology is really being rendered obsolete.
- 19:07SPEAKER_00: We are shifting from fixing a broken machine to coaching a biological environment.
- 19:12SPEAKER_00: We aren't swapping out parts anymore.
- 19:14SPEAKER_00: We are sending elite project managers and waterproof blueprints to the construction site.
- 19:19SPEAKER_00: We are learning how to speak the body's own cellular language.
- 19:24SPEAKER_01: It's incredible.
- 19:24SPEAKER_01: And it raises an important question, right?
- 19:26SPEAKER_01: If we can master this language, what are the actual limits of human healing?
- 19:31SPEAKER_00: It completely redefines what we consider a permanent injury.
- 19:35SPEAKER_00: We started this deep dive talking about the sci-fi fantasy of the glowing healing pod, but the physical reality we are uncovering might be even more profound.
- 19:44SPEAKER_00: Total.
- 19:45SPEAKER_00: If we are currently learning how to use ethically sourced stem cells and their XSO messenger packets to calm toxic inflammation and successfully coach a severely damaged brain back toward health, what other seemingly permanent, stubborn conditions might eventually be unlocked just by learning how to rewrite the cellular text messages our bodies are sending to each other?
- 20:04SPEAKER_00: The blueprints for healing might already be inside us, we just needed to figure out how to hit send.